Mathijs Goossens
Overview
Explore the profile of Mathijs Goossens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goossens M, Tran T
Eur J Public Health
. 2025 Mar;
PMID: 40037772
The European Commission Initiative on Breast Cancer recommends pre-scheduled appointments to enhance attendance in population-based mammography screening programmes (PMSP). Pre-scheduled appointments often lead to no-shows, resulting in inefficient use of...
2.
Ferrari A, Tran T, Hoeck S, Peeters M, Goossens M, Van Hal G
Eur J Public Health
. 2023 Nov;
34(2):347-353.
PMID: 38006217
Background: Despite the recognized benefits of structured cancer screening, tests outside organized screening programs are common. Comprehensive reports on outside program screening in Europe are lacking, but the Flemish breast...
3.
De Meester D, Goossens M, Marco E, Claessens M, Gautier J, Annweiler C, et al.
Clin Nutr ESPEN
. 2023 Sep;
57:65-72.
PMID: 37739719
Objective: To determine whether the Geriatric Nutritional Risk Index (GNRI) on hospital admission was associated to an increased 14-day and 12-month mortality-risk in older inpatients with COVID-19. Methods: Cohort study...
4.
Andersson N, Thiesson E, Baum U, Pihlstrom N, Starrfelt J, Faksova K, et al.
BMJ
. 2023 Jul;
382:e074325.
PMID: 37487623
Objective: To investigate the comparative vaccine effectiveness of heterologous booster schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and with homologous mRNA vaccine booster schedules (three...
5.
Hatem G, Itani R, Ajrouche R, Abbas N, Farah R, Goossens M, et al.
J Med Access
. 2023 Jan;
7:27550834221147789.
PMID: 36685148
Background: Many governments encouraged generic use to enhance health equality and minimise health expenditure. The lack of knowledge and acceptance of generic medicines are the main barriers to their use....
6.
Ding L, Greuter M, Truyen I, Goossens M, van der Vegt B, De Schutter H, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230754
Background: Screening program effectiveness is generally evaluated for breast cancer (BC) as one disease and without considering the regularity of participation, while this might have an impact on detection rate....
7.
Hatem G, Ismaiil L, Awada S, Ghanem D, Assi R, Goossens M
Eval Health Prof
. 2022 Sep;
45(4):420-424.
PMID: 36070355
The implementation of continuing education programs for pharmacists in Lebanon is emerging and needs to be further developed and strengthened to fill the gaps between knowledge acquisition and its application...
8.
Ding L, Poelhekken K, Greuter M, Truyen I, De Schutter H, Goossens M, et al.
Eur J Cancer
. 2022 Jul;
173:1-9.
PMID: 35839596
Background: Overdiagnosis of invasive breast cancer (BC) is a contentious issue. Objective: The aim of this paper is to estimate the overdiagnosis rate of invasive BC in an organised BC...
9.
Hatem G, Ghanem D, Kellen E, AlZaim I, Goossens M
Cancer Control
. 2021 Oct;
28:10732748211053149.
PMID: 34706582
Background: Lebanon has an increasing cancer burden. Sufficient knowledge of cancer risk factors and early cancer symptoms can help lower cancer burden by facilitating primary prevention and early diagnosis. This...
10.
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles C, et al.
Breast
. 2020 Mar;
51:65-84.
PMID: 32217457
This article is an update of the requirements of a specialist breast centre, produced by EUSOMA and endorsed by ECCO as part of Essential Requirements for Quality Cancer Care (ERQCC)...